Characteristic | All (N = 160) | COVID-19 patients (N = 100) | CAP patients (N = 60) | P-value |
---|---|---|---|---|
Male gender, N (%) | 97 (60.6) | 65 (65.0) | 32 (53.3) | 0.20 |
Age, median (IQR) | 60.5 (48.0–71.3) | 57.0 (47.8–67.0) | 64.0 (54.0–78.3) | 0.01 |
Comorbid conditions, N (%) | ||||
Stroke | 5 (3.1) | 1 (1.0) | 4 (6.7) | 0.13 |
Myocardial infarction | 3 (1.9) | 0 (0.0) | 3 (5.0) | 0.10 |
Heart arrhythmia | 4 (2.5) | 2 (2.0) | 2 (3.3) | 1.00 |
Asthma | 2 (1.3) | 0 (0.0) | 2 (3.3) | 0.27 |
Bronchiectasis | 1 (0.6) | 0 (0.0) | 1 (1.7) | 0.80 |
Active cancer | 4 (2.5) | 1 (1.0) | 3 (5.0) | 0.30 |
Dementia | 2 (1.3) | 0 (0.0) | 2 (3.3) | 0.27 |
Diabetes mellitus | 17 (10.6) | 8 (8.0) | 9 (15.0) | 0.26 |
Coronary disease | 5 (3.1) | 1 (1.0) | 4 (6.7) | 0.13 |
Mental illness | 1 (0.6) | 1 (1.0) | 0 (0.0) | 0.80 |
Interstitial lung disease | 5 (3.1) | 1 (1.0) | 4 (6.7) | 0.13 |
Chronic kidney disease | 5 (3.1) | 1 (1.0) | 4 (6.7) | 0.13 |
Heart failure | 2 (1.3) | 0 (0.0) | 2 (3.3) | 0.27 |
Arterial hypertension | 61 (38.1) | 39 (39.0) | 22 (36.7) | 0.90 |
Obesity | 6 (3.8) | 4 (4.0) | 2 (3.3) | 0.83 |
Supplementary oxygen | 8 (5.0) | 1 (1.0) | 7 (11.7) | 0.01 |
OSAHS | 3 (1.9) | 2 (2.0) | 1 (1.7) | 0.65 |
Former/Active smoker | 8 (5.0) | 6 (6.0) | 2 (3.3) | 0.71 |
Tracheostomy | 1 (0.6) | 0 (0.0) | 1 (1.7) | 0.80 |
COPD | 18 (11.3) | 4 (4.0) | 14 (23.3) | < 0.01 |
No conditions | 62 (38.8) | 43 (43.0) | 19 (31.7) | 0.21 |
Vital signs at admission, median (IQR) | ||||
Heart rate | 90.0 (78.0–103.0) | 86.5 (78.0–100.3) | 93.5 (78.6–110.5) | 0.15 |
Respiratory rate | 20.0 (18.0–24.3) | 20.0 (18.0–25.0) | 20.0 (15.0–15.0) | 0.88 |
Glasgow score | 15.0 (15.0–15.0) | 15.0 (15.0–15.0) | 15.0 (15.0–15.0) | 0.01 |
Systolic blood pressure | 120.0 (105.8–131.0) | 121.0 (110.0–131.0) | 116.0 (100.0–130.5) | 0.20 |
Diastolic blood pressure | 70.0 (62.8–80.0) | 71.5 (65.0–80.0) | 70.0 (60.0–80.0) | 0,41 |
Treatments and interventions | ||||
Hospital length of stay, median (IQR) | 8.0 (5.0–11.0) | 8.0 (5.8–12.3) | 7.0 (4.0–11.0) | 0.16 |
Mechanical ventilation, N (%) | 57 (35.6) | 41 (41.0) | 16 (26.7) | 0.10 |
ICU admission, N (%) | 70 (43.8) | 49 (49.0) | 21 (35.0) | 0.12 |
Dexamethasone, N (%) | 85 (53.1) | 80 (80.0) | 5 (8.3) | < 0.01 |
Outcomes, N (%) | ||||
In-hospital mortality | 22 (13.8) | 17 (17.0) | 5 (8.3) | 0.19 |